The estimated Net Worth of Kevin R Thornal is at least $9.17 Million dollars as of 15 November 2022. Mr. Thornal owns over 19,118 units of Hologic stock worth over $4,990,064 and over the last 5 years he sold HOLX stock worth over $1,439,968. In addition, he makes $2,740,300 as Division President and Diagnostics at Hologic.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Thornal HOLX stock SEC Form 4 insiders trading
Kevin has made over 3 trades of the Hologic stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 19,118 units of HOLX stock worth $1,439,968 on 15 November 2022.
The largest trade he's ever made was selling 19,118 units of Hologic stock on 15 November 2022 worth over $1,439,968. On average, Kevin trades about 2,771 units every 51 days since 2019. As of 15 November 2022 he still owns at least 62,368 units of Hologic stock.
You can see the complete history of Mr. Thornal stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kevin Thornal biography
Kevin R. Thornal serves as Division President, Diagnostics of the Company. Mr. Thornal became the President of our Diagnostics Division in July 2019. He joined Hologic in 2014 as Vice President, Customer Experience, Field Service and Clinical Applications for the Breast and Skeletal Health division. He transitioned to Vice President, Breast and Skeletal Health for the Europe, Middle East and Africa region in early 2016, and was promoted to President of Hologic’s Medical Aesthetics Division in July 2017. Prior to joining Hologic, Mr. Thornal worked at Stryker from 2004 to 2014 in positions of increasing responsibility in sales, marketing, and mergers and acquisitions. Throughout his career, he has established a track record of leading businesses that deliver strong growth and commercial excellence. Mr. Thornal previously played professional football, including a short stint with the Atlanta Falcons. He holds a Bachelor of Arts in History, with minors in English and Secondary Education, from Southern Methodist University.
What is the salary of Kevin Thornal?
As the Division President and Diagnostics of Hologic, the total compensation of Kevin Thornal at Hologic is $2,740,300. There are 2 executives at Hologic getting paid more, with Stephen MacMillan having the highest compensation of $12,374,800.
How old is Kevin Thornal?
Kevin Thornal is 46, he's been the Division President and Diagnostics of Hologic since 2019. There are 18 older and 1 younger executives at Hologic. The oldest executive at Hologic, Inc. is Dr. Jay A. Stein, 78, who is the Co-Founder, Chairman Emeritus, CTO & Sr. VP.
What's Kevin Thornal's mailing address?
Kevin's mailing address filed with the SEC is C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065.
Insiders trading at Hologic
Over the last 30 years, insiders at Hologic have traded over $311,276,394 worth of Hologic stock and bought 385,967 units worth $8,452,795 . The most active insiders traders include Carl Chigh River Limited Pa..., Carl C Icahn, and Stephen P Macmillan. On average, Hologic executives and independent directors trade stock every 22 days with the average trade being worth of $3,042,940. The most recent stock trade was executed by Karleen Marie Oberton on 29 August 2024, trading 52,679 units of HOLX stock currently worth $4,243,820.
What does Hologic do?
driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.
What does Hologic's logo look like?
Complete history of Mr. Thornal stock trades at Hologic and Nevro Corp
Hologic executives and stock owners
Hologic executives and other stock owners filed with the SEC include:
-
Stephen MacMillan,
Chairman of the Board, President, Chief Executive Officer -
Stephen P. MacMillan,
Chairman, CEO & Pres -
Kevin Thornal,
Division President, Diagnostics -
John Griffin,
General Counsel -
Peter Valenti,
Division President - Breast and Skeletal Health -
Karleen Oberton,
Chief Financial Officer -
Kevin R. Thornal,
Division Pres of Diagnostic Solutions -
John M. Griffin,
Gen. Counsel -
Sean S. Daugherty,
Group Pres of Breast/Skeletal Health & GYN Surgical Solutions -
Sally Crawford,
Lead Independent Director -
Ludwig Hantson,
Independent Director -
Charles Dockendorff,
Independent Director -
Scott Garrett,
Independent Director -
Namal Nawana,
Independent Director -
Amy Wendell,
Independent Director -
Christiana Stamoulis,
Independent Director -
Michael Watts,
Vice President - Investor Relations and Corporate Communications -
Allison Bebo,
Senior Vice President - Human Resources -
Mike Kelly,
Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs -
Paul Malenchini,
Chief Information Officer -
Elisabeth A. Hellmann,
Sr. VP of Global HR & Corp. Communications -
Ryan Simon,
VP of Investor Relations -
Monica Aguirre Berthelot,
Chief of Staff -
Sanjay Prabhakaran,
Regional Pres of Asia Pacific -
Jan Verstreken,
Group Pres of International -
Dr. Jay A. Stein,
Co-Founder, Chairman Emeritus, CTO & Sr. VP -
Elaine Ullian,
Director -
Nancy Leaming,
Director -
Thomas A. West,
Div President & GM, Diagnostic -
Christopher J Coughlin,
Director -
Eric B. Compton,
COO -
Robert W. Mc Mahon,
Chief Financial Officer -
Lawrence M Levy,
Director -
Carl Hull,
SVP and GM of Diagnostics -
Peter Soltani,
Vice President -
Benjamin Jordan Cohn,
Principal Accounting Officer -
Steven S. Williamson,
SVP, GYN Surgical -
John R Pekarsky,
Sr. VP, Sales -
Howard Jr Doran,
Vice President & BUD, ThinPrep -
Arthur G Lerner,
Director -
Laurie Fajardo,
Director -
Robert Cascella,
President & COO -
William A Peck,
Director -
Stuart A Kingsley,
President, Surgical Division -
Irwin Jacobs,
Director -
C William Mcdaniel,
Director -
Stetten Eric Von,
Vice President -
Daniel J Levangie,
Director -
Patrick J Sullivan,
Director -
Wayne Wilson,
Director -
Jay A Stein,
Director -
Samuel J. Merksamer,
Director -
Jonathan Christodoro,
Director -
David R Jr Lavance,
Director -
Claus Egstrand,
SVP and GM, International -
Carl Chigh River Limited Pa...,
-
Rohan Hastie,
Group VP & GM, Diagnostics -
Roger D. Mills,
SVP & GM, Service & Operations -
Robert H Lavallee,
Vice President -
Mark J Casey,
Senior V.P & General Counsel -
Carl C Icahn,
10% owner -
David Harding,
SVP, International -
David J Brady,
SVP, Human Resources -
Glenn P Muir,
Executive VP & CFO -
John W Cumming,
Chairman & CEO -
Sean S. Daugherty,
Group President, BSH & Surg. -
Jan Verstreken,
Group President, International -
Nanaz Mohtashami,
Director -
Brandon Schnittker,
Div. President, GYN Surgical -
Elisabeth A Hellmann,
SVP, Human Resources -
Erik S Anderson,
Div. Pres., Breast & Skeletal -
Essex D Mitchell,
Div. President, GYN Surgical -
Stacey D. Stewart,
Director -
Jennifer M Schneiders,
President, Diag. Solutions -
Peter Paul Dunne,
SVP, Human Resources